Monisha Javadi, Padmavathi Ganesan, Roy Nand Kishor, Deka Anindita, Bordoloi Devivasha, Anip Anand, Kunnumakkara Ajaikumar B
Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam-781039, Room # 005, O-Block.
Curr Pharm Des. 2016;22(27):4173-200. doi: 10.2174/1381612822666160609110231.
Despite the significant developments made in the field of diagnosis and treatment modalities of cancer during the last two decades, it still remains one of the most life threatening diseases killing 8.2 million people annually across the globe. It has been well-established that development of chemoresistance in cancer cells is the major cause of failure of chemotherapeutic agents in clinic. Most of the chemotherapeutic agents currently being used activate NF-κB and NF-κB regulated gene products in cancer cells and induce drug resistance. Increasing lines of evidences suggest that NF-κB blockers have high potential in decreasing drug resistance and sensitize cancer cells to chemotherapeutic agents.
A through literature search was carried out in pubmed to identify natural NF-κB inhibitors that possess high potential in sensitizing cancer cells.
Our literature search retrived a number of NF-κB inhibitors that have been identified during the last several years. Notably, the inhibitors obtained from Mother Nature such as curcumin, tocotrienol, resveratrol, garcinol etc. are found to be highly safe, efficacious and inexpensive. Many preclinical and clinical studies have revealed that these agents can block the activation of NF-κB in cancer cells to overcome drug resistance and make them sensitive to chemotherapeutic agents.
Both basic and clinical research revealed that constitutive activation of NF-κB is the prime reason for inducing drug resistance in cancer cells. This comprehensive review scientifically evaluates the chemosensitizing potential of these natural agents which serve as potent NF-κB blockers, based on evidence based literature.
尽管在过去二十年里癌症的诊断和治疗方式领域取得了重大进展,但它仍然是最具生命威胁的疾病之一,全球每年有820万人死于癌症。已经明确的是,癌细胞中化疗耐药性的产生是临床化疗药物失败的主要原因。目前使用的大多数化疗药物会激活癌细胞中的核因子κB(NF-κB)及其调控的基因产物,并诱导耐药性。越来越多的证据表明,NF-κB阻断剂在降低耐药性和使癌细胞对化疗药物敏感方面具有很大潜力。
在PubMed上进行了全面的文献检索,以确定具有使癌细胞敏感化潜力的天然NF-κB抑制剂。
我们的文献检索找到了过去几年中已确定的多种NF-κB抑制剂。值得注意的是,从大自然中获得的抑制剂,如姜黄素、生育三烯酚、白藜芦醇、藤黄脂等,被发现具有高度安全性、有效性且价格低廉。许多临床前和临床研究表明,这些药物可以阻断癌细胞中NF-κB的激活,以克服耐药性并使其对化疗药物敏感。
基础研究和临床研究均表明,NF-κB的组成性激活是癌细胞诱导耐药性的主要原因。本综述基于循证文献,科学评估了这些作为有效NF-κB阻断剂的天然药物的化学增敏潜力。